. Purpose: Early and consistent evaluation of cardiac morphology and function throughout an atrophic stimulus is critically important for the design and optimization of interventions. This randomized controlled trial was designed 1) to characterize the time course of unloading-induced morphofunctional remodeling and 2) to examine the effects of exercise with and without low-dose testosterone supplementation on cardiac biomarker, structural, and functional parameters during unloading. Methods: Twenty-six subjects completed 70 d of head-down tilt bed rest (BR): 9 were randomized to exercise training (Ex), 8 to EX and low-dose testosterone (ExT), and 9 remained sedentary (CONT). Exercise consisted of high-intensity, continuous, and resistance exercise. Cardiac morphology (left ventricular mass [LVM]) and mechanics (longitudinal, radial, and circumferential strain and twist), cardiovascular biomarkers, and cardiorespiratory fitness (V O 2peak ) were assessed before, during, and after BR. Results: Sedentary BR resulted in a progressive decline in LVM, longitudinal, radial, and circumferential strain in CONT, whereas Ex and ExT mitigated decreases in LVM and function. Twist was increased throughout BR in sedentary BR, whereas after an initial increase at BR7, there were no further changes in twist in Ex and ExT. HDL cholesterol was significantly decreased in all groups compared with pre-BR (P G 0.007). There were no significant changes in other cardiovascular biomarkers. Change in twist was significantly related to change in V O 2max (R = 0.68, P G 0.01). Conclusion: An integrated approach with evaluation of cardiac morphology, mechanics, V O 2peak , and biomarkers provides extensive phenotyping of cardiovascular atrophic remodeling. Exercise training and exercise training with low-dose testosterone supplementation abrogates atrophic remodeling.
T he heart responds with remarkable morphofunctional plasticity and adaptability in response to various stimuli (1) . In recent years, although the extent and functional consequences of pathological (2) and physiological hypertrophy (3) have been studied intensively, little is known regarding the impact, magnitude, and time course of atrophic remodeling. Emerging evidence indicates that unveiling these mechanisms may be of central importance for numerous populations exposed to mechanical unloading (e.g., physical inactivity, prolonged bed rest [BR] [4] , weightlessness during space travel (5), or augmented catabolic state [e.g., cancer] [6] ). Importantly, early and consistent evaluation of cardiac morphology and function throughout an atrophic stimulus is critically important for the design and optimization of interventions.
Exercise training is one intervention that has been shown to abrogate declines in left ventricular mass (LVM) and function during unloading (7) ; nevertheless, the format and intensity of exercise required to induce optimal cardiac improvements has not been investigated. Notably, the maintenance of LVM and function is a key determinant of cardiorespiratory fitness (V O 2peak ) (8) , a strong predictor of both all-cause and cardiovascular disease (CVD) mortality (9) .
Testosterone therapy is another intervention prescribed to patients exposed to atrophic stimuli (10) that has been shown to significantly increase muscle strength and bone mineral density (11) , even at lower doses (12) . However, the effects of androgens on the cardiovascular system remain incompletely understood (13) , and the effects of exercise training with concurrent low-dose testosterone supplementation on atrophic cardiovascular remodeling have not been investigated in humans.
This randomized controlled trial was designed 1) to comprehensively characterize the time course of unloadinginduced morphofunctional remodeling and 2) to examine the effects of high-intensity exercise training and low-dose testosterone with concurrent high-intensity exercise training on cardiac structural and functional parameters.
METHODS
Subjects, setting, and procedures. Twenty-six subjects completed 70 d of 6-head-down tilt BR. Full details of the study methods are reported in companion paper (Cromwell et al.) . In brief, subjects were recruited and screened in two phases according to the standard National Aeronautics and Space Administration (NASA) Flight Analog Project procedures. Subjects with a history of musculoskeletal injury that could affect exercise performance or expose the subject to an increased risk of injury were excluded from the study. Subjects were confined to BR for the entire 70 d, including personal hygiene, although they were allowed to raise up on one elbow for meals only. Diets were strictly controlled (55% carbohydrate, 30% fat, and 15% protein).
To obtain matched groups, subjects were stratified by baseline characteristics (Table 1 ) and then randomly assigned to three study groups: 9 were randomized to exercise training (Ex), 8 to EX and testosterone (ExT), and 9 remained sedentary (CONT). All study procedures were reviewed and approved by NASA and University of Texas Medical Branch institutional review boards. All subjects signed a written consent before the initiation of any study-related procedures.
Exercise training. The countermeasure consisted of high-intensity aerobic training combined with resistive strength exercise as described previously (14) . Subjects exercised 6 dIwk j1 . Supine aerobic exercise was performed using the Standalone Zero Gravity Locomotion Simulator vertical treadmill and a supine cycle ergometer, and resistance exercise was performed on the Horizontal Exercise Fixture. Highintensity interval aerobic exercise and continuous aerobic exercise were performed on alternating days. Resistance exercise was performed 3 dIwk j1 on the same day as the continuous aerobic exercise, separated by 4-6 h. The aerobic exercise intensities were prescribed as a percentage of V O 2peak achieved during the pre-BR upright peak cycle test. Exercise intensity was assessed one time per week throughout BR during a continuous, 2-min interval, or 4-min interval aerobic exercise session as described previously (15) . Continuous exercise intensity was targeted at 80% of V O 2peak . For the interval days, one of three interval protocols were performed: 1) 6 Â 2-min stages at target intensities of 70%, 80%, 90%, 100%, 90%, and 80% of V O 2peak with a 2-min rest; 2) 8 Â 30-s at maximal effort with a 15-s active rest; and 3) 4 Â 4 min at a target intensity of 85% V O 2peak with a 3-min active rest. Each interval was performed once per week. Heart rate was monitored continuously during training sessions. Resistance exercise sessions consisted of three sets of 6, 8, or 12 repetitions (alternating each resistance day) on each of four lifts (supine squat, supine leg press, supine heel raise, and prone lying leg curl).
Testosterone treatment. The countermeasure consisted of a low-dose, intermittent testosterone regimen throughout the BR period. Placebo (Ex and CONT; saline) or testosterone enanthate injections (ExT; 100 mgIwk j1 , intramuscular) were administered in 2-wk intervals during BR (injections occurred on BR1, BR7, BR28, BR35, BR56, and BR63).
Cardiorespiratory fitness. Cardiorespiratory fitness was assessed during peak cycle ergometry tests (Lode Excalibur Sport; Lode B.V., Groningen, the Netherlands) performed before (BRj3), during (BR4, BR25, BR46, and BR68), and after (BR+0) BR. Peak tests were performed in the upright position before and after BR and were performed supine during BR. The protocol consisted of a 3-min warm-up at 50 W, followed by 25-W increases each minute. Tests were terminated at volitional fatigue. HR and rhythm were monitored continuously (Q-Stress ECG monitor; Quinton Instruments, Seattle, WA). Metabolic gas exchange was measured continuously during exercise and averaged over 30-s intervals (ParvoMedics TrueOne 2400, Sandy, UT). Peak V O 2 was defined as the highest V O 2 value for a given 30-s interval within the last 60 s of exercise.
Cardiac structure and function. Participants underwent 2-D transthoracic and pulsed-Doppler imaging by use of a commercial ultrasound system (iE33, Phillips Healthcare) at least 12 h after the most recent training session before (BRj2), during (BR7, BR21, BR31, and BR70), and after (BR+0 and +3) BR. Images were obtained by experienced, registered sonographers in the long axis, short axis, and apical four-chamber views according to the American Society of Echocardiography guidelines.(16) Cardiac structural measurements were made in accord with current guidelines, and LVM was obtained through 3-D quantification. LV volumes were calculated using the biplane Simpson method. The LV length was measured in the apical 4-chamber view and was defined as the end-diastolic length from the mitral valve hinge point plane to the most distal endocardium at the LV apex (17) . Pulsed Doppler recordings were used to assess diastolic filling; in particular, early (E) and atrial (A) peak mitral inflow velocities were measured, and the ratio of early to late diastolic filling velocity (E:A) was calculated. Tissue Doppler data were used to assess E ¶. Images were analyzed offline by a single experienced technician blinded to group allocation. A minimum of three consecutive cardiac cycles were measured and averaged. Resting heart rates were obtained on the final loop of each study, and blood pressures were obtained daily at 0600 h.
LV strain, twist, and untwisting. Radial displacements, circumferential and radial strain, and strain rate data were averaged between the basal and the apical slices. The apical window was used for longitudinal strain assessment. In both orientations, frame rates were maximized (960 frames per second). For the purpose of LV rotation assessment, short-axis imaging standardization within and across subjects was maximized using the following criteria. The basal level was defined as the highest basal imaging plane at which uniform full thickness myocardium was observed surrounding the mitral valve at end-systole. As the location of apical imaging acquisition has been shown to confer significant variability in the measurement of apical rotation, we carefully standardized apical imaging. Specifically, from multiple apical acquisitions distal to the papillary muscles, the apical level was chosen as the imaging plane with no visible papillary muscles that most closely approximated an end-diastolic ratio of LV cavity diameter to total LV diameter of 0.5 (17) . Using the original 2-D images, a single experienced technician performed offline measurements of the longitudinal, radial, and circumferential planes using a dedicated software package (Q-Lab, Phillips Healthcare). This system tracks acoustic markers within the myocardium, frame by frame, over the entire cardiac cycle. The spatial displacement of an acoustic marker indicates local tissue movement. A tracking setting was selected with a width between endocardium and epicardium to include as much myocardium as possible. Sonographer-specific coefficient of variation data ranged from 4.9% to 7.1% for strain and twist. A minimum of three consecutive cardiac cycles were measured and averaged. All data were exported to a spreadsheet program (Excel; Microsoft Corporation, Redmond, WA). Cubic spline interpolation (Matlab; Mathworks, Natick, MA) was used to determine data points at 2% increments of systolic duration throughout the cardiac cycle (18) . To adjust all parameters for intersubject differences in heart rate and imaging frame rate, event timing was calculated as a percentage of systole, with the onset of QRS being 0% and aortic valve closure equivalent to 100%. For each participant, systole occurred from 0% to 100%, whereas diastole was from 100% onward. Peak systolic LV twist was calculated as the maximum instantaneous difference between peak systolic apical and basal rotation. The timing of peak systolic LV twist was determined as a percentage of systolic duration. Peak early diastolic untwisting rate was defined as the peak untwisting velocity occurring in early diastole. The LV twist is reported as absolute and as LV length-corrected values.
Cardiac biomarkers and plasma volume. Venous blood samples were obtained from fasting participants and immediately processed and stored at j80-C. For each blood sample, 5 mL of whole blood was drawn from an antecubital vein and collected in serum-gel tubes before (BRj3), during (BR28), and after (BR+0 and BR+5) BR. Ten cardiovascular biomarkers were measured: cholesterol, LDL and HDL, triglyceride, C-reactive protein, phospholipids, superoxide dismustase, hematocrit, hemoglobin, and total antioxidant capacity. Biochemical analyses were performed by standard commercial techniques, as described previously (19) .
Plasma volume was assessed four times (BRj2, BR7, BR31, and BR+0) using the carbon monoxide rebreathing technique as previously reported (20) . Briefly, the subjects breathed 100% oxygen for 2 min through a closed breathing circuit fitted with a two-way nonrebreathing valve (Model 2700; Hans Rudolph, Kansas City, MO). Carbon monoxide (60 mL) was then added to the system and was rebreathed for 10 min. Plasma volume was then calculated.
Statistical analysis. All statistical analyses were performed using Stata, IC software (v 141, StataCorp LP, College Station, TX), setting two-tailed alpha to reject the null hypothesis at 0.05. All of our outcomes are continuously scaled and appropriately analyzed with parametric statistical techniques; all statistical assumptions were tested before interpreting results. Statistical assumptions were tested before hypothesis testing by careful residual evaluations. Subjects_ repeated-measures outcomes were submitted to a mixed-effects linear regression analysis with a priori contrasts comparing baseline (pre-BR) to each of the subsequent six observations made during and post-BR. Random y-intercept terms were included to accommodate for the repeated-measures experimental design, and Bonferroni adjustments to P values were used to adjust for the inflated type I error risk associated with multiple comparisons. The data from all of our outcomes met the distributional requirements for the techniques used without requiring data transformations or nonlinear modeling; however, we did eliminate occasional observations when the standardized residual exceeded T3.0. This resulted in no more than one of 63 possible observations being eliminated from any given analysis. Data are expressed as using either mean T SD or with 95% confidence intervals.
RESULTS
Cardiorespiratory fitness. Compared with pre-BR, V O 2peak was significantly decreased in all groups at BR4 (P G 0.007): CONT (BRj2: 2.9 T 0.6 LImin j1 vs BR4: 2.5 T 0.4 LImin ). After the initial decline at BR4, there were no significant differences from pre-BR at any other time point for Ex and ExT groups; V O 2peak was significantly decreased at all other time points in the CONT group (P G 0.007).
Cardiac structure, resting heart rate, and blood pressure. Time course of change in cardiac structural measurements is detailed in Table 2 . Image quality was sufficient to obtain 3-D LVM in 25 subjects. Among the 25 subjects with a possible total of 175 images, image quality was sufficient in 94%. LV atrophy developed in CONT subjects. Specifically, there was a significant decrease in LV end-diastolic volume, internal diameter wall thickness, and LVM commencing at BR7 (P G 0.007). No change in structural measurements occurred throughout BR in Ex or ExT groups. There was no change in systolic or diastolic blood pressures in any group. Resting heart rate was preserved in Ex (BRj2: 56 T 8 bpm; BR70: 61 T 9 bpm; BR+0: 67 T 8 bpm) and ExT (BRj2: 58 T 9 bpm; BR70: 59 T 7 bpm; BR+0: 61 T 10 bpm); however, resting heart rate was significantly increased in CONT subjects at time points BR70 and BR+0 (BRj2: 62 T 9 bpm; BR70: 75 T 12 bpm; BR+0: 93 T 9 bpm; P G 0.007).
Cardiac function: conventional and tissue Doppler parameters. Time course of change in measures of cardiac systolic and diastolic parameters is detailed in Table 3 . There was no change in LV ejection fraction in any group. Diastolic function assessed by E/A and E ¶ was preserved in Ex and ExT groups but was significantly decreased in the CONT group (P G 0.007) beginning at BR7.
Cardiac function: LV rotation, LV twist, and untwisting. LV strain, twist, and untwist data are summarized in Table 4 . Image quality was sufficient to obtain LV strain and twist in 25 subjects. Among the 25 subjects with a possible total of 175 images, image quality was sufficient to obtain longitudinal strain, radial strain, circumferential strain, and twist in 94%, 93%, 92%, and 92%, respectively. Longitudinal strain and circumferential strain were unaffected in the three groups throughout BR. Compared with pre-BR, there was a significant decrease in radial strain at BR70 and BR+0 in the CONT group; no differences were observed in the exercise groups. At BR7, there was a significant increase in peak systolic apical rotation but no change in basal rotation, which translated into a significant increase in peak systolic LV twist in all groups. There were no significant differences from pre-BR at any other time point for Ex and ExT groups. Apical rotation and LV twist were significantly increased at all other time points in the CONT group compared with pre-BR (P G 0.007). Peak early diastolic untwisting was increased significantly in the CONT group at BR7, BR21, BR31, BR70, and BR+0. The time to peak apical and basal rotation and LV twist did not change significantly throughout BR in any group. Finally, with all groups combined, there was a significant correlation between change in peak systolic LV twist and change in V O 2peak (r 2 = 0.61, P G 0.001). Cardiac biomarkers and plasma volume. Results from the blood chemistry panel are presented in Table 5 . HDL cholesterol was significantly decreased in all groups compared with pre-BR (P G 0.007). C-reactive protein was significantly increased in the CONT group at BR+5 compared with pre-BR; no changes were observed in the exercise groups. There were no significant changes in other cardiovascular biomarkers. Compared with pre-BR, plasma volume was significantly decreased in all groups at BR7 (P G 0.01): CONT (BRj2: 3.0 T 0.4 L, BR7: 2.5 T 0.4 L), Ex (BRj2: 3.2 T 0.5 L, BR7: 2.7 T 0.5 L), and ExT (BRj2: 3.0 T 0.4 L, BR7: 2.7 T 0.4 L). There were no significant differences from pre-BR at BR31 in any group; plasma volume was significantly 
DISCUSSION
We present novel, longitudinal data describing the time course of atrophic cardiovascular remodeling and the cardioprotective effects of exercise training and low-dose testosterone supplementation. The principal new findings from this study were as follows: 1) alterations in cardiac morphology and function begin early (within 7 d of disuse); 2) augmentation in twist is an early indicator of cardiac adaptation to unloading; 3) the cardiovascular alterations that occur with sedentary BR were prevented by an integrated exercise program consisting of high-intensity aerobic exercise and strength training; and 4) this integrated exercise training with concurrent low-dose testosterone supplementation also mitigates atrophic cardiovascular remodeling. These findings suggest that an integrated approach with evaluation of cardiac morphology, LV mechanics, V O 2peak , and biomarkers may be important complementary tools to characterize the overall cardiovascular impact of unloading. In turn, early identification of these cardiovascular alterations would help guide frequency of monitoring and optimize timing and type of interventions, including exercise.
Time Course of Cardiovascular Remodeling during Unloading
This is the first study to conduct temporal measures to comprehensively characterize the time course of both functional and morphological cardiovascular alterations; prior studies examining the cardiovascular impact of unloading consisted of pre-and postmeasures. We found that significant declines in cardiac morphology, alterations in diastolic function and LV twist, and V O 2peak occurred within the first 7 d of BR and persisted throughout disuse, significant increases in resting heart rate were observed toward the end of 70 d of unloading, and surprisingly few changes in cardiovascular biomarkers were observed. An outline of the integrated time course of remodeling is provided in Figure 1 .
Cardiac morphology. The changes in cardiac structure during short-and long-term BR have been under investigation for several years. Our present findings support earlier data by Perhonen et al. (4) that showed that the overall heart size (including both volume and mass) decreased after 2 wk of horizontal BR and appeared to plateau after 5 wk of BR. Indeed, we found decreases in LVM and end-diastolic volume at BR7 and BR21 compared with pre-BR, with little change thereafter. The initial changes in cardiac structure are thought to be the results of decreases in volume; within 24 h of a head-ward fluid shift, there is a salt and water diuresis, with a reduction in central venous pressure and stroke volume below supine values (5). Our present findings support earlier data suggesting that after stabilization of fluid changes, changes in cardiac myocyte cell size occurring after periods of disuse longer than 70 d could contribute to decreases in LVM (5). Nevertheless, echocardiographic estimates of LVM are dependent on LV volumes; cardiac magnetic resonance imaging is currently considered the reference technique for LV morphology measurements (21) .
Cardiac mechanics. Global measures of LV function, such as LVEF, are typically unchanged after unloading. LVEF, however, is load, rate, and contractility dependent, and acute declines in myocardial function can be masked by initial compensations in LV mechanics that maintain cardiac output (22) . Thus, LVEF change is a late marker, only becoming evident after significant alterations in cardiac performance have already occurred. Speckle tracking assessment of systolic function with strain is more sensitive for detecting altered myocardial performance beyond LVEF (23) . In the clinical setting, reduced strain and strain rate revealed impaired myocardial function before LVEF decline (24) in cancer patients treated with anthracycline-containing therapy. Interestingly, we found no change in longitudinal or circumferential strain after 70 d of BR, suggesting alterations in these planes may also occur later in the remodeling sequelae. We found that that LV apical rotation was altered, and not LV basal rotation, which is consistent with other myocardial deformation studies in athletes (25) and with the notion that the magnitude of apical counterclockwise rotation is the primary determinant of overall peak systolic LV twist. Initial increases in twist (within 7 d) may be due to alterations in loading. Indeed, a decrease in LV loading results in a compensatory increase in LV twist (26) , as does increased vascular loading (27) . Similar to previous studies reporting, an acute loss of plasma volume (20) we found by BR7 plasma volume was significantly decreased in all groups, suggesting that increases in twist observed at BR7 may be due to decreased preload (26) . Importantly, however, chronic changes in LV twist in CONT may be due to specific alterations in the subendocardial layer. Normally, the subendocardial and subepicardial layers oppose each other during contraction due to their oblique fiber angle orientations (28) . Greater force is generated in the epicardial layer as a result of the longer distance from the center of the ventricle (28) . Previous research in healthy aging has demonstrated that subendocardial shortening is reduced, resulting in less opposition to epicardial contraction, ultimately leading to greater LV twist at rest (28) . Combining the assessment of comprehensive LV mechanical function with indicators of molecular remodeling would further advance the current understanding of physiological adaptation of LV mechanics.
Cross-sectional reports have identified differences in LV twist when comparing cyclists and sedentary controls (29) ; specifically, individuals with high-peak oxygen consumption had significantly lower apical rotation and twist. Here, we found a similar relationship between peak twist and aerobic capacity at the other end of the spectrum: a low peak oxygen consumption was associated with a high LV twist. Importantly, the change in aerobic capacity was associated with the change in LV twist, suggesting an important interplay between cardiac mechanics and exercise tolerance. It is possible that a high resting twist results in little ''twist reserve'' with exercise (28) , which significantly impairs the ability of the heart to augment preload and, thus, increase cardiac output. We did not assess cardiac function during stress; future studies should assess the role of twist reserve on aerobic capacity and exercise tolerance. Resting heart rate. Resting heart rate is a simple measure that can provide information regarding relative effects of autonomic tone in a given state (30) . We found a progressive increase in resting heart rate throughout disuse; by BR70, resting heart rate was 21% (13 bpm) higher. These findings highlight the potential time course of autonomic dysregulation, with changes occurring within 2 months of a stimulus onset. Importantly, epidemiological studies show that resting heart rate is an independent predictor of CVD and all-cause mortality in individuals with and without diagnosed CVD disease (30) , suggesting that interventions are crucial early on.
Cardiac biomarkers. The identification of biomarkers that predict risk of CVD could provide insight into the biology of the disease and could aid in developing targeted prevention strategies during the preclinical phase of CVD, when intervention may be more likely to alter disease progression. Previous studies have reported evidence of a shift toward a less healthy whole body metabolic profile during extreme reductions in activity (19) ; accordingly, we characterized the time course of change in several established cardiovascular biomarkers that are mechanistically relevant to CVD pathogenesis (31) . We found no other alterations in cardiac biomarkers. In the current investigation, the diet was tightly controlled and consisted of a 55% carbohydrate (4.97 T 0.30 gIkg j1 ), 30% fat (1.21 T 0.07 gIkg j1 ), and 15% protein (1.36 T 0.08 gIkg j1 ) macronutrient profile. These findings highlight the important role of diet in preventing metabolic alterations and CVD pathogenesis.
Cardioprotective effects of exercise training. Several investigators have used exercise training to prevent cardiovascular deconditioning associated with BR. For example, Watenpaugh et al. (32) used supine treadmill running during simultaneous lower body negative pressure to establish a similar cardiovascular stress to exercise training in the 1G upright position and found upright exercise capacity was preserved. Similarly, Hastings et al. (33) reported that exercise training maintained cardiac size, function, and aerobic capacity. The present report is consistent with and extends these previous studies by demonstrating that despite early fluid shift-induced alterations in LV function and a decrease in cardiorespiratory fitness, a comprehensive training program incorporating submaximal intensity base training, higher-intensity intervals, and regular resistance training completely mitigates atrophic functional and morphological cardiovascular remodeling. In the primary compensatory phase, there was a decline in tissue velocity and V O 2peak and an increase in twist relative to pre BR. During the acute adaptation phase, there was a decline in LVM and radial strain, maintenance of tissue velocity and V O 2peak , and decline in twist relative to primary compensatory phase. In the secondary compensatory response phase, there was a further decline in tissue velocity and V O 2peak and an increase in twist and resting HR relative to the acute adaptation phase. In the final chronic adaptation phase, there were declines in longitudinal strain and circumferential strain, augmentation in resting HR, and maintenance of increased twist and decreased V O 2peak , LVM, and tissue velocity. LV, left ventricular; HR, heart rate.
Implications of exercise training with low dose testosterone supplementation. Testosterone, given its role in bone and muscle maintenance, is often considered as a potential countermeasure for unloading-induced atrophy. Testosterone is known to promote muscle protein synthesis (34) , and several studies have shown that chronic administration of testosterone increases lean body and muscle mass and improves muscle strength (35) . The heart is also a target organ for steroids; there are receptors with a high affinity for testosterone in cardiomyocytes (36) , suggesting testosterone supplementation may also impact cardiac function. Here, we found similar cardiovascular responses between Ex and ExT groups, supporting two salient findings: 1) the addition of low-dose testosterone supplementation does not further enhance an already cardioprotective stimulus (i.e., exercise), and 2) low-dose testosterone does not significantly alter cardiac function. These findings suggest that although there may be no supplementary cardiovascular benefit to low-dose testosterone, low-dose androgen administration could be safely implemented as a muscle or bone countermeasure.
Implications
Physical inactivity is rapidly becoming a major global concern and is the fourth leading cause of death worldwide (37) . Evidence indicates that physical inactivity increases the relative risk of coronary artery disease, stroke, and hypertension by 45%, 60%, and 30%, respectively (38) . Moreover, the health care costs of sedentary individuals are close to one-third higher than those of individuals who are physically active, representing at least 100 billion US dollars in excess health care costs (39) . Exercise, in contrast, is a nonpharmacological, pleiotropic intervention that has the unique capacity to modulate, without toxicity, a plethora of cardiovascular-specific molecular and cell-signaling pathways implicated in inactivityinduced alterations. Indeed, we found that exercise intervention mitigated a 27%, 22%, 20%, and 14% decline in LV twist, V O 2peak , LVM, and resting HR, respectively. Together, these data indicate that exercise training and maintenance of physical fitness have important impacts on the prevalence and progression of CVD in humans.
Limitations and Future Directions
Several limitations and areas for future work are noteworthy. First, we performed a serial assessment of resting cardiac function and thus cannot comment on how our observations relate to myocardial function during exercise. To completely determine the physiological importance of atrophic remodeling, there is a need to move beyond the study of LV function at rest. Evaluation of the myocardial response to hemodynamic/exercise challenge may ultimately represent a method for characterizing exercise performance and also aid in characterizing cardiovascular remodeling. Second, V O 2peak reflects the integrative capacity of the cardiovascular and musculoskeletal system to transport and use oxygen (O 2 ) for ATP synthesis (40) . Here, we focused on the cardiac-specific aspects contributing to aerobic capacity; the contributions of musculoskeletal atrophy to decrements in functional performance were examined in a companion paper. Third, we evaluated relatively young, healthy subjects. This limits the generalizability of our findings to disease states and older populations.
CONCLUSIONS
The present study demonstrated that broad phenotyping integrating cardiac morphology, LV mechanics, V O 2peak , and biomarkers could guide timing and optimization of interventions that may delay or prevent the onset of atrophic remodeling resulting from spaceflight, BR, augmented catabolic state, reduction in physical activity, or aging. To this end, our findings suggest that the cardiovascular alterations that occur with sedentary BR can be mitigated both by an integrated exercise program consisting of high-intensity aerobic exercise and strength training and exercise training with concurrent low-dose testosterone supplementation.
